FDA Inspection 670230 — Vitalant

Vitalant — FEI 2077574

The FDA completed an inspection of Vitalant on June 27, 2010 in Ventura, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 27, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ventura, CA (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
922521 CFR 606.171Biological product deviation report